Decitabine with GemOx

Phase 2Small molecule

SSeoul National University Hospital

Decitabine with GemOx is one of 6 small molecule programs targeting T-ALL. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

T-ALLRecruiting

T-ALLPhase 2

Recruiting

Competition

Competitive Landscape

8 competitors in T-ALL

#DrugCompanyPhaseTrials

Venclexta

AbbVie

Phase 2

2 2

Cytosar

Teva

Phase 2

1 3

Sarclisa

AAzienda U.S.L. 1 di Massa e Carrara

Phase 2

1 4

Homoharringtonine

Ascentage Pharma Group Inc.

Phase 2

1 5

G-CSF

AArog Pharmaceuticals, Inc.

Phase 2

1 6

Decitabine with GemOx

SSeoul National University Hospital

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2028

Phase 2Recruiting

T-ALL

NCT06712121

Clinical

Trials by Indication[1]

T-ALL1 trial

Venetoclax and Decitabine in R/R T-ALL

Recruiting·SSeoul National University Hospital·Phase 2·NCT06712121·28 enrolled

Lymphoma1 trial

Evaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell Lymphoma

Terminated·SSeoul National University Hospital·Phase 2·NCT06941688·17 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Decitabine with GemOx. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Decitabine with GemOx compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Decitabine with GemOx. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Seoul National University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: SSeoul National University Hospital

Decitabine with GemOx

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2028

Trials by Indication[1]

T-ALL1 trial

Lymphoma1 trial

References

Drug Info

Quick Facts

Related News